Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
HRS8807
i
Other names:
HRS8807, HRS-8807, HRS 8807
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Jiangsu Hengrui Pharma
Drug class:
Selective estrogen receptor covalent antagonist
‹
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
ER positive
HER2 Negative Breast Cancer
ER positive
HER2 Negative Breast Cancer
HRS8807
Sensitive: C3 – Early Trials
HRS8807
Sensitive
:
C3
HRS8807
Sensitive: C3 – Early Trials
HRS8807
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.